What drove WLLW.TO stock down to C$0.035?

The drop reflects microcap volatility, recent selling pressure and broader Healthcare weakness. High intraday volume of **3,804,082** shares amplified the move and pushed the WLLW.TO stock below key moving averages.

Does Willow Biosciences have cash to support a rebound in WLLW.TO stock?

Yes. Willow reports **cash per share C$1.15** and book value per share **C$1.13**, which gives the microcap balance-sheet support and underpins speculative bounce scenarios for WLLW.TO stock.

What price targets should traders watch for WLLW.TO stock?

Watch **C$0.06** as a conservative target, **C$0.10** as Meyka baseline, and **C$0.12** as a bull case. Use a downside stop near **C$0.02** to manage risk on WLLW.TO stock.

How reliable is the Meyka AI forecast for WLLW.TO stock?

Meyka AI's model offers systematic projections; it forecasts **C$0.10** for WLLW.TO stock. Models use historical and fundamental data and are not guarantees, so combine them with your own research.

CA Stocks

C$0.035 WLLW.TO Willow Biosciences (TSX) market closed 18 Mar 2026: bounce risk

ByHuzaifa Zahoor March 19, 2026March 19, 2026

WLLW.TO stock closed at C$0.035 on the TSX on 18 Mar 2026, with volume spiking to 3,804,082 shares. The sharp drop left the share price well below the 50-day average of C$0.14 and the 200-day average of C$0.25. That disconnect sets a classic oversold bounce setup for Willow Biosciences Inc. Traders should weigh the heavy intraday volume and microcap risks against company cash metrics and potential short-term rebounds.